Should You Tell Your Doctor After IVF in Hong Kong and Returning to Mainland China? Cross-border Medical Handover Essentials
Do you need to inform your doctor after IVF in Hong Kong and returning to Mainland China? This article from a reproductive medicine perspective clearly answers: Yes, you must. Covers gestational age calculation differences, luteal phase support handover, medical record organization, management points for different ages, and real cases to help patients safely complete cross-border medical handover.
Opening: Real consultation scenario
Consultation scenario: A 34-year-old woman left a message on an online consultation platform: "I had IVF in Hong Kong, and I've returned after a successful pregnancy test. When I go to the community hospital to register my medical records, should I tell the doctor that I conceived through IVF? I'm afraid of being treated differently if I tell, but I'm also worried about potential problems if I don't."
Every day, a large number of patients who have completed IVF treatment in Hong Kong or overseas and returned to Mainland China face the same dilemma when registering for antenatal checkups. As a reproductive medicine doctor, my advice is very clear: You must inform, and the sooner and more completely, the better.
Direct Answer: You Must Tell the Doctor
There are essential differences in medical management between IVF pregnancies and natural pregnancies. Not informing the doctor is equivalent to letting the obstetrician make decisions with incomplete information, which introduces avoidable risks.
- Different gestational age calculation: The gestational age for IVF is calculated from the transfer date, which can differ by more than 2 weeks from the last menstrual period calculation. An incorrect gestational age can shift the timing of key checks like NT, Down's screening, and glucose tolerance test.
- Luteal phase support needs handover: The types, dosages, and methods of luteal phase support medications commonly used in Hong Kong and Mainland China may differ. A doctor's assessment is needed for a smooth transition; you should not stop or change medication on your own.
- Embryo information affects antenatal decisions: Whether PGT screening was done, embryo grading, and whether it's a singleton or twin pregnancy directly relate to the frequency of antenatal checkups, amniocentesis recommendations, and pregnancy risk assessment.
- High-risk pregnancy management: IVF pregnancies are classified under "high-risk pregnancy" management in obstetric guidelines, requiring closer monitoring, including early coagulation function, thyroid function, and blood glucose screening.
Shared Perspective of Obstetricians and Reproductive Doctors
From an obstetrician's perspective, understanding the method of conception is fundamental to assessing risk. An experienced obstetrician routinely asks about the "method of conception" during consultations, not out of curiosity, but because IVF pregnancies require special attention in the following areas:
- Gestational age calibration: Gestational age for frozen embryo transfer = transfer date + 17 days (cleavage stage embryo) or + 19 days (blastocyst). Fresh embryo transfer requires additional consideration of the egg retrieval date. The obstetrician needs this information to accurately estimate the due date.
- Luteal function assessment: Early IVF pregnancies require exogenous luteal phase support. The timing of discontinuation should be determined by the doctor based on hormone levels and embryonic development, not decided independently.
- Multiple pregnancy management: The probability of twins is significantly higher for patients who had 2 embryos transferred. The frequency of antenatal checkups, nutritional management, and preterm birth prevention for twin pregnancies are completely different from singletons.
- Placenta-related risks: Some studies show a slightly increased risk of placenta accreta, placenta previa, and gestational hypertension in IVF pregnancies, requiring early warning.
From a reproductive doctor's perspective, the ideal approach for patients returning to Mainland China is: obtain complete medical records before leaving Hong Kong, and as soon as you return, schedule an appointment with an obstetrics or reproductive genetics clinic to complete the information handover.
Specific Steps After Returning from Hong Kong to Mainland China
Step 1: Obtain Complete Hong Kong IVF Medical Records
Before leaving Hong Kong, request the following documents from the fertility center (usually available as free copies or electronic versions):
- Ovarian stimulation protocol record (medication names, dosages, duration)
- Egg retrieval record (number of eggs retrieved, number of mature eggs)
- Embryo culture report (fertilization method, embryo development, grading)
- Embryo transfer record (transfer date, embryo type, catheter number)
- PGT screening report (if performed)
- Post-transfer medication plan and hormone monitoring results (E2, P, HCG)
Step 2: Organize and Translate Medical Records
Medical records in Hong Kong are often in Traditional Chinese or English. It is recommended to compile a summary of key information in Simplified Chinese to facilitate quick reading by Mainland doctors. Highlight: transfer date, embryo type, luteal phase support plan, and PGT results.
Step 3: Proactively Inform During Antenatal Registration
When registering at a community hospital or general hospital obstetrics department, directly present the organized medical record summary and verbally state: "I had IVF in Hong Kong, and this is the complete treatment record." There is no need to be overly nervous; obstetricians encounter IVF pregnancy patients daily; it is routine information.
Step 4: Handover Luteal Phase Support Plan
Discuss the current medication plan with the doctor to confirm if adjustments are needed. The luteal phase support medications commonly used in Hong Kong are generally compatible with those in Mainland China, but dosages and formulations may require fine-tuning.
5 Most Easily Overlooked Details
- Incorrect gestational age calculation: Many patients calculate gestational age using the "last menstrual period," leading to a due date deviation of over 2 weeks, directly affecting the timing of NT and glucose tolerance tests.
- Switching between Crinone and progesterone injections: Crinone (vaginal gel) is common in Hong Kong, while progesterone injections or oral dydrogesterone are common in Mainland China. Dose equivalence must be considered when switching; a simple 1:1 replacement is not appropriate.
- Not showing PGT results to the obstetrician: For patients who had PGT-A or PGT-M, the embryo chromosome screening results directly affect the interpretation of NIPT and amniocentesis; they must be given to the obstetrician for filing.
- Delayed confirmation of twins: Some patients in Hong Kong do not have an early ultrasound to confirm singleton or twin pregnancy. After returning to Mainland China, an ultrasound should be done as soon as possible at 6-8 weeks gestation to determine the number of gestational sacs.
- Incomplete medication records: Some patients only remember "taking progesterone" but not the dosage and frequency, making it difficult for the doctor to determine if the dose was adequate. It is recommended to keep a detailed table record.
4 Most Common Pitfalls
Pitfall 1: Concealing IVF history — Worried about being "treated differently" and choosing not to disclose, leading the doctor to manage the pregnancy as natural, missing the early intervention window for luteal phase insufficiency, increasing the risk of miscarriage.
Pitfall 2: Stopping luteal phase support on your own — Finding it "troublesome" or having "no symptoms" after returning to Mainland China and stopping medication, causing luteal withdrawal in early pregnancy, triggering contractions or bleeding.
Pitfall 3: Miscalculating gestational age and missing key checks — Using the last menstrual period to calculate gestational age, leading to the NT scan (11-13⁺⁶ weeks) being scheduled after 14 weeks, losing its screening value.
Pitfall 4: Not disclosing twin pregnancy — The frequency of antenatal checkups, nutritional needs, and preterm birth prevention for twin pregnancies are completely different from singletons. Not disclosing twins can lead to inappropriate management plans.
Key Management Points for Different Age Groups
| Age Group | Risk Characteristics | Management Focus |
|---|---|---|
| Under 35 | Overall low risk, but IVF pregnancy still falls under high-risk category | Accurate gestational age calculation, handover luteal phase support, routine antenatal checkups |
| 35 – 39 years | Age + IVF dual high-risk factors | Increase frequency of antenatal checkups, early screening for blood glucose and coagulation function, monitor placental function |
| 40 years and above | Very high-risk pregnancy, significantly increased risk of complications | Must fully disclose all information, recommended to register at a tertiary hospital obstetrics department for multidisciplinary management |
Case Scenario Analysis
Case 1: Failure to disclose led to checkup error
A 32-year-old woman had one frozen blastocyst transferred in Hong Kong and did not disclose her IVF history after returning to Mainland China. The community doctor calculated gestational age based on the last menstrual period, resulting in an actual gestational age 12 days less than calculated. The NT scan was scheduled at "13 weeks," when the actual gestational age was only 11⁺² days. Although barely within the window, risk communication was skewed. Later, an ultrasound showed fetal growth inconsistent with the gestational age, and the truth only came out after further questioning.
Case 2: Proactive disclosure led to precise management
A 39-year-old woman had one frozen blastocyst transferred in Hong Kong and proactively provided complete medical records after returning to Mainland China. Based on her age and IVF pregnancy, the obstetrician classified her as high-risk, completed early blood glucose screening and coagulation function tests at 12 weeks, and NIPT at 16 weeks. The entire pregnancy went smoothly, and she delivered at full term.
Practitioner's Observation: A Reproductive Doctor's Honest Advice
In clinical practice, I encounter patients every year who return from Hong Kong or overseas and don't know how to manage their pregnancy care. Summarizing, the two most prominent issues are:
- Not knowing what to disclose: Many patients think saying "I had IVF" is enough, but doctors actually need specific information like the transfer date, embryo type, medication plan, and PGT results.
- Not knowing how to obtain medical records: Some patients leave Hong Kong without requesting their records, needing to apply for them later, which is a cumbersome and time-consuming process. It is recommended to obtain a complete treatment record before leaving.
Regarding the concern about "being treated differently" — in fact, obstetricians and gynecologists in Mainland China already have sufficient knowledge and management experience with IVF pregnancies. Proactive disclosure only allows the doctor to assess the situation more accurately and will not lead to "different treatment." On the contrary, concealing the history may lead to unnecessary tests, misjudgment, and delays.
Key Information Checklist to Tell Your Doctor
| Information Category | Specific Content | Purpose |
|---|---|---|
| Transfer Date | Year/Month/Day, and specify cleavage stage embryo or blastocyst | Accurately calculate gestational age and due date |
| Embryo Type | Fresh / Frozen; Cleavage stage / Blastocyst | Affects gestational age calculation formula and risk assessment |
| Embryo Grading | e.g., 4AA, 4AB, 3BB, etc. | Assess embryo developmental potential, aid in judging pregnancy progression |
| PGT Screening Results | Whether PGT-A or PGT-M was performed, and the results | Directly affects prenatal diagnosis plan (NIPT / Amniocentesis) |
| Luteal Phase Support Plan | Medication name, dosage, method, start and end times | Handover medication, avoid luteal phase insufficiency |
| Hormone Monitoring Records | Historical values of E2, P, HCG after transfer | Assess embryo development trend, determine if intervention is needed |
Reference for Handover of Common Luteal Phase Support Medications: Hong Kong vs. Mainland China
| Medication Category | Common in Hong Kong | Common in Mainland China | Handover Notes |
|---|---|---|---|
| Vaginal Gel | Crinone 8% gel | Crinone 8% gel / Anqitan 200mg | Can continue using the same product, dosage usually unchanged |
| Injectable | Progesterone injection 25mg/50mg | Progesterone injection 20mg/40mg | Need to verify single dose to avoid conversion errors |
| Oral | Dydrogesterone 10mg | Dydrogesterone 10mg | Usage and dosage are consistent, can be continued directly |
Risk Reminder:
After returning from Hong Kong to Mainland China, it is recommended to complete the first antenatal checkup within 6-8 weeks of pregnancy to confirm the location, number of gestational sacs, and fetal heartbeat, and bring all Hong Kong medical records. If you experience abdominal pain, vaginal bleeding, elevated blood pressure, or other abnormalities, seek medical attention immediately and proactively disclose your IVF pregnancy history. Pregnancy management is a continuous process; the completeness and accuracy of information are directly related to the safety of both mother and baby. Do not conceal your medical history because of "trouble" or "embarrassment" — this is the most fundamental step in taking responsibility for yourself and your fetus.
0 comments